Survival Outcomes in Patients With Locally Advanced NSCLC Converted to Resectable Disease by Neoadjuvant Therapy.

In Vivo · 2026 · PMC12764256 · PMID 41482392

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Regarding OS, only mediastinal lymph node involvement demonstrated a significant impact on mortality risk (HR=3.50, 95% CI=1.18-10.4; p =0.024), whereas angiolymphatic invasion (HR=2.65, 95% CI=0.88-7.99; p =0.084) and receiving ≥3 neoadjuvant cycles (HR=6.94, 95% CI=0.85-56.9; p =0.071) did not reach statistical significance ( Figure 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.